Tracon Pharmaceuticals, Inc. Contracts & Agreements

Amended Non-Employee Director Compensation Policy (Filed With SEC on May 14, 2024)

License Agreement, dated November 17, 2023, by and between the Registrant and Inhibrx, Inc (Filed With SEC on March 5, 2024)

Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on March 9, 2023)

Securities Purchase Agreement, dated March 9, 2023, by and between TRACON Pharmaceuticals, Inc. and the purchaser listed on Exhibit A thereto (Filed With SEC on March 9, 2023)

Investment Agreement, dated December 22, 2022, by and between the Registrant and Batiste Investments LLC (Filed With SEC on March 8, 2023)

Severance Agreement by and between the Registrant and Bonne Adams, dated September 27, 2017 (Filed With SEC on March 8, 2023)

Employment Agreement by and between the Registrant and Bonne Adams, dated February 27, 2017 (Filed With SEC on March 8, 2023)

TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended February 1, 2023 (Filed With SEC on March 8, 2023)

First Amendment to Loan and Security Agreement, dated December 22, 2022, by and between the Registrant and Runway Growth Finance Corp (Filed With SEC on March 8, 2023)

Loan and Security Agreement by and among the Company, each other party thereto as a borrower from time to time, the lenders from time to time party thereto and Runway Growth... (Filed With SEC on September 6, 2022)

Form of Warrant to Purchase Common Stock (Filed With SEC on September 6, 2022)

Form of Pre-Funded Warrant (Filed With SEC on June 21, 2022)

Form of Amended and Restated Pre-Funded Warrant 1 (Filed With SEC on June 21, 2022)

Form of Amended and Restated Pre-Funded Warrant 2 (Filed With SEC on June 21, 2022)

Securities Purchase Agreement, between the Company and the Purchaser, dated June 21, 2022 (Filed With SEC on June 21, 2022)

TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended January 28, 2022 (Filed With SEC on March 15, 2022)

Collaborative Development and Commercialization Agreement by and among the Registrant, Eucure (Beijing) Biopharma Co., Ltd. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd.... (Filed With SEC on November 3, 2021)

Amended and Restated Underwriting Agreement, dated July 21, 2021, by and between TRACON Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 22, 2021)

TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended January 29, 2021 (Filed With SEC on February 25, 2021)

TRACON Pharmaceuticals, Inc. Bonus Plan, as amended January 29, 2021 (Filed With SEC on February 25, 2021)

Employment Agreement by and between the Registrant and Mark Wiggins, dated January 27, 2021 (Filed With SEC on February 25, 2021)

Amendment #2 to Cooperative Research and Development Agreement by and between the Registrant and the U.S. Department of Health and Human Services, as represented by National... (Filed With SEC on February 25, 2021)

Deferral agreement to Amended and Restated Loan and Security Agreement between the Registrant and Silicon Valley Bank dated April 10, 2020 (Filed With SEC on April 15, 2020)

TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended January 31, 2020 (Filed With SEC on February 28, 2020)

Description of Capital Stock (Filed With SEC on February 28, 2020)

Employment Agreement by and between the Registrant and Scott Brown, dated January 28, 2020 (Filed With SEC on February 28, 2020)

Collaboration and Clinical Trial Agreement by and among the Registrant, 3D Medicines (Beijing) Co., LTD. and Jiangsu Alphamab Biopharmaceuticals Co., LTD. dated December 20, 2019 (Filed With SEC on February 28, 2020)

Severance Agreement by and between the Registrant and Scott Brown, dated December 4, 2019 (Filed With SEC on February 28, 2020)

TRACON Pharmaceuticals, Inc. Bonus Plan, as amended January 28, 2020 (Filed With SEC on February 28, 2020)

Amendment No. 1 to Capital on DemandTM Sales Agreement, dated as of February 28, 2019, by and between the Registrant and JonesTrading Institutional Services LLC (Filed With SEC on November 5, 2019)

Registration Rights Agreement, dated October 18, 2019, between TRACON Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)

Employment Agreement by and between the Registrant and Mark Wiggins, dated May 29, 2018 (Filed With SEC on March 1, 2019)

Amendment One to License and Option Agreement between the Registrant and Janssen Pharmaceutica N.V. dated January 15, 2019 (Filed With SEC on March 1, 2019)

Amended and Restated Employment Agreement by and between the Registrant and Charles P. Theuer, M.D., Ph.D., dated February 5, 2019 (Filed With SEC on March 1, 2019)

Severance Agreement by and between the Registrant and Mark Wiggins, dated May 29, 2018 (Filed With SEC on March 1, 2019)

Warrant dated May 3, 2018, issued to Silicon Valley Bank (Filed With SEC on May 10, 2018)

TRACON Pharmaceuticals, Inc. Bonus Plan, as amended February 21, 2018 (Filed With SEC on May 10, 2018)

Third Amendment to Amended and Restated Loan and Security Agreement between the Registrant and Silicon Valley Bank dated May 3, 2018 (Filed With SEC on May 10, 2018)

Manufacturing Agreement (the Agreement) (Filed With SEC on March 27, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 14, 2017)

TRACON PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT For CHARLES P. THEUER (Filed With SEC on March 1, 2017)

TRACON PHARMACEUTICALS, INC. SEVERANCE PLAN SEVERANCE AGREEMENT (Filed With SEC on March 1, 2017)

TRACON PHARMACEUTICALS, INC. BONUS PLAN (Filed With SEC on March 1, 2017)

TRACON PHARMACEUTICALS, INC. SEVERANCE PLAN AMENDED AND RESTATED SEVERANCE AGREEMENT (Filed With SEC on March 1, 2017)

TRACON PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT For PATRICIA BITAR (Filed With SEC on March 1, 2017)

TRACON PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT For H. CASEY LOGAN (Filed With SEC on March 1, 2017)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 31, 2017)

SECOND Amendment to AMENDED AND RESTATED Loan and security agreement (Filed With SEC on January 31, 2017)

TRACON PHARMACEUTICALS, INC. BONUS PLAN (Filed With SEC on December 21, 2016)

TRACON Pharmaceuticals, Inc. 2,625,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 23, 2016)

INVESTOR AGREEMENT By and Between JOHNSON & JOHNSON INNOVATION-JJDC, INC. AND TRACON PHARMACEUTICALS, INC. Dated as of September 27, 2016 Table of Contents (Filed With SEC on November 9, 2016)

FIRST Amendment to AMENDED AND RESTATED Loan and security agreement (Filed With SEC on August 11, 2016)

TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on August 11, 2016)

SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on February 19, 2016)

SEVERANCE AGREEMENT AS AMENDED (Filed With SEC on February 19, 2016)

Amendment #2 Cooperative Research and Development Agreement #02661 “Development of the Human Chimeric Monoclonal Antibody TRC105, an Angiogenesis Inhibitor Provided by Tracon... (Filed With SEC on February 19, 2016)

FOURTH AMENDMENT TO LEASE (Filed With SEC on February 19, 2016)

AMENDMENT #2 Cooperative Research and Development Agreement #02663 “Clinical Development of Tracon Pharmaceuticals Inc.’s TRC105, an anti-CD105 antibody, as an Anti-Cancer... (Filed With SEC on February 19, 2016)

SEVERANCE AGREEMENT (Filed With SEC on November 4, 2015)

8910 University Center Lane Suite 700 San Diego, California 92122 P: 858 ###-###-#### F: 858 ###-###-#### URL: (Filed With SEC on November 4, 2015)

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on May 14, 2015)

TRACON PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT For CHARLES P. THEUER (Filed With SEC on May 14, 2015)

TRACON Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan Adopted by the Board of Directors: January 1, 2015 Approved by the Stockholders: January 16, 2015 (Filed With SEC on May 14, 2015)

AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on May 14, 2015)

TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on May 14, 2015)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 14, 2015)

THIRD AMENDMENT (Filed With SEC on March 11, 2015)

TRACON Pharmaceuticals, Inc. [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 20, 2015)

Additional abbreviations may also be used though not in the above list. (Filed With SEC on January 20, 2015)

TRACON PHARMACEUTICALS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: JANUARY 1, 2015 APPROVED BY THE STOCKHOLDERS: [], 2015 IPO DATE: [], 2015 (Filed With SEC on January 20, 2015)

TRACON PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on January 20, 2015)

LICENSE AGREEMENT (Filed With SEC on January 20, 2015)

PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH (Filed With SEC on December 29, 2014)

TRACON PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT September 19, 2014 (Filed With SEC on December 29, 2014)

INDEMNITY AGREEMENT (Filed With SEC on December 29, 2014)

TRACON PHARMACEUTICALS, INC. 2011 EQUITY INCENTIVE PLAN EFFECTIVE AS OF AUGUST 10, 2011 AMENDED AS OF SEPTEMBER 19, 2014 (Filed With SEC on December 29, 2014)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 29, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on December 29, 2014)

SPONSORED RESEARCH AGREEMENT (Filed With SEC on December 29, 2014)

PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR NCI DIVISION OF CANCER TREATMENT AND DIAGNOSIS (DCTD) EXTRAMURAL PHS CLINICAL RESEARCH (Filed With SEC on December 29, 2014)

TRACON Pharmaceuticals, Inc. 8910 University Center Lane, Suite 700 San Diego, California 92122 Phone: 858 ###-###-#### Fax: 858 ###-###-#### Website: www.traconpharma.com (Filed With SEC on December 29, 2014)

PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR EXTRAMURAL-PHS CLINICAL RESEARCH (Filed With SEC on December 29, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on December 29, 2014)

WARRANT TO PURCHASE STOCK (Filed With SEC on December 29, 2014)

LICENCE AGREEMENT between LONZA SALES AG and TRACON PHARMACEUTICALS INC (Filed With SEC on December 29, 2014)

LICENSE AGREEMENT Case Western Reserve University Tracon Pharmaceuticals Inc. (Filed With SEC on December 29, 2014)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 29, 2014)

LICENSE AGREEMENT (Filed With SEC on December 29, 2014)

THE AVENTINE OFFICE LEASE (Filed With SEC on December 29, 2014)

SEVERANCE AGREEMENT (Filed With SEC on December 29, 2014)

TRACON PHARMACEUTICALS, INC. SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION Plan Effective Date: June 2, 2014 (Filed With SEC on December 29, 2014)

Category

Industry

Companies

Contracts

Tracon Pharmaceuticals, Inc. Contracts & Agreements